Notably, CXCR3 blockade during late-stage CD8 T cell responses in influenza-cleared lungs can mitigate lung injury without affecting viral clearance, suggesting therapeutic potential for preventing influenza-associated lung injury (208). Here, CD8A is linked to influenza.